The peripheral blood inflammatory patterns in the control levels of asthma in children

Orhan Coşkun1, Nazli Ercan2, Ilknur Bostanci3

  • 1Department of Child Health and Diseases, Health Sciences University, Dr. Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey.

Insights

Eosinophil percentage in children can indicate asthma control levels. This study suggests it may serve as a useful marker for monitoring pediatric asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Immunology
  • Laboratory Medicine

Background:

  • Asthma is a prevalent chronic inflammatory childhood disease.
  • Current diagnostic and follow-up methods for pediatric asthma lack easily accessible laboratory tests.
  • There is a need for reliable inflammatory markers to assess asthma control in children.

Purpose of the Study:

  • To investigate the utility of white blood cell (WBC) count, platelet count, mean platelet volume (MPV), and eosinophil percentage as inflammatory markers.
  • To evaluate the role of these markers in assessing asthma control and guiding follow-up in pediatric patients.
  • To identify accessible laboratory tests for routine use in pediatric asthma management.

Main Methods:

  • Retrospective review of 3,580 pediatric asthma patient records from Turkey.
  • Patients categorized into controlled and uncontrolled asthma groups based on established criteria.
  • Comparison of laboratory data, including eosinophil percentage, between asthma control groups, considering atopy and medication status.

Main Results:

  • A total of 348 pediatric patients (4-18 years) were included in the final analysis.
  • Significantly higher eosinophil percentages were observed in the uncontrolled asthma group compared to the controlled group (p=0.003).
  • Logistic regression analysis confirmed eosinophil percentage as a significant predictor of asthma control status (OR=1.276).

Conclusions:

  • Eosinophil percentage emerges as a potential indicator for monitoring asthma control in children.
  • This finding suggests eosinophil percentage could be a valuable, accessible laboratory parameter for pediatric asthma management.
  • Further prospective studies are recommended to validate these findings and solidify its role in clinical practice.
Abstract

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K